ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 51 filers reported holding ENZO BIOCHEM INC in Q4 2013. The put-call ratio across all filers is 16.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $224,000 | +58.9% | 20,266 | +20.6% | 0.01% | +50.0% |
| Q1 2017 | $141,000 | +67.9% | 16,800 | +1.4% | 0.00% | +100.0% |
| Q3 2016 | $84,000 | +61.5% | 16,562 | +44.1% | 0.00% | +100.0% |
| Q4 2015 | $52,000 | +73.3% | 11,492 | +14.8% | 0.00% | 0.0% |
| Q2 2015 | $30,000 | -74.4% | 10,013 | -74.7% | 0.00% | -50.0% |
| Q1 2015 | $117,000 | -81.3% | 39,519 | -66.8% | 0.00% | -80.0% |
| Q2 2014 | $625,000 | +1288.9% | 119,057 | +1008.3% | 0.01% | +900.0% |
| Q1 2014 | $45,000 | +66.7% | 10,742 | +0.3% | 0.00% | – |
| Q3 2013 | $27,000 | – | 10,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |